Angeion Corporation Introduces the MedGraphics CCM Express(R), a New Product for the Critical Care Market

Angeion Corporation (NASDAQ:ANGN) today announced a new product, the MedGraphics CCM Express® monitor, designed to measure the nutritional requirements of patients in hospital intensive care units (ICU) and critical care units (CCU). The CCM Express is significantly smaller, easier to use and more cost effective than other products currently available. The system was demonstrated at the annual meeting of the European Respiratory Society in Stockholm, Sweden, and received great interest. The CCM Express is an extension of MedGraphic’s core technology and expertise in determining patients’ respiratory function. This monitor is used to assess the caloric and supplemental nutrition needs of hospitalized patients who can’t eat or those who require intravenous or other specialized feeding techniques such as in the intensive care or critical care unit. The measurement is based upon the patient’s inhaled and exhaled breath. This technology is used to accurately measure the optimal nutritional requirements of acutely ill patients and to assist in transitioning these patients from ventilator support to breathing on their own. "Underfeeding or overfeeding is a common problem in critically ill patients,” Rod Young, President and CEO, commented. "Better management of their nutrition and body fuel needs can shorten their length of stay in the ICU and reduce their hospitalization costs. The advanced technology in CCM Express enables the product to take up less space in the ICU or CCU and is much easier to use than other devices. These enabling features are highly important in the high-tech ICU/CCU environment; CCM Express represents a new generation of indirect calorimeters.” According to market data, approximately 3,400 hospitals in the United States have intensive care units with 4.5 to 5 million patients admitted for intensive care annually. Research has shown that patients who received correct nutritional support averaged a decreased length of stay in the intensive care unit of approximately 1.5 days at a cost savings to the health care system of approximately $4,000 per patient. MedGraphics products are used in hospitals and physician offices around the world for diagnosing and helping to manage therapy for patients with cardiopulmonary diseases. About Angeion Corporation Founded in 1986, Angeion Corporation acquired Medical Graphics Corporation in December 1999. Medical Graphics develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems that are sold under the MedGraphics (www.medgraphics.com) and New Leaf (www.newleaffitness.com) brand and trade names. These cardiorespiratory diagnostic systems have a wide range of applications in healthcare as well as health and fitness. The Company’s products are sold internationally through distributors and in the United States through a direct sales force that targets heart and lung specialists located in hospitals, university-based medical centers, medical clinics and physicians’ offices, pharmaceutical companies, medical device manufacturers, clinical research organizations, health and fitness clubs, personal training studios, and other exercise facilities. For more information about Angeion, visit www.angeion.com.